Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sexual dysfunction in multiple sclerosis: A 6-year follow-up study.
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
PDE4B as a microglia target to reduce neuroinflammation.
Information provision for people with multiple sclerosis.
Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis.
Development of a cell-based assay for the detection of anti-aquaporin 1 antibodies in neuromyelitis optica spectrum disorders.
Unfavorable outcomes during treatment of multiple sclerosis with high doses of vitamin D.
Anesthetic management of a patient with multiple sclerosis undergoing cesarean section with low dose epidural bupivacaine.
Vitamin D insufficiency and chronic diseases: Hype and reality.
The specific antigen approach in multiple sclerosis: Can it ever be enough?
[Expression of human B-cell specific receptor FCRL1 in normal individuals and in patients with autoimmune diseases].
Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patients.
Anxiety and depressive symptoms in caregivers of multiple sclerosis patients: The role of information processing speed impairment.
Understanding Biomarkers of Neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.
Reply to Article: High inbreeding in the Faroe Islands does not appear to constitute a risk factor for multiple sclerosis.
Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis.
Initiating oral fingolimod treatment in patients with multiple sclerosis.
Temporal reorganization to overcome monocular demyelination.
Oropharyngeal dysphagia in patients with multiple sclerosis: do the disease classification scales reflect dysphagia severity?
Molecular triggers of neuroinflammation in mouse models of demyelinating diseases.
New data presented at 29th ECTRIMS congress reinforce the clinical profile of investigational laquinimod on disease progression and inflammation in relapsing-remitting multiple sclerosis
Accuracy of Postcontrast 3D Turbo Spin Echo MR Sequence for the Detection of Enhanced Inflammatory Lesions in Patients with Multiple Sclerosis.
Multiple sclerosis in Syria.
Clarification on neuromuscular conditions in careers article.
Sexual disparities in the incidence and course of MS.
Pages
« first
‹ previous
…
329
330
331
332
333
334
335
336
337
…
next ›
last »